Riskpilot← Back to searchSign inGet full accessZENOUMED ApS
APSActiveCVR 33958943Peder Skrams Vej 27Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20111 employeeswww.zenoumed.com
Revenue 2024
DKK -101K
-38% vs 2023
EBITDA margin
651.7%
+25% vs 2023
Equity ratio
65.8%
Financial strength
Net profit 2024
DKK -526K
+30% vs 2023
| Revenue | DKK -101K | -38% |
| EBITDA | DKK -659K | +25% |
| Net profit | DKK -526K | +30% |
| Total assets | DKK 2M | -22% |
| Equity | DKK 1,3M | -28% |
| Employees | 1 | — |
Legal name
ZENOUMED ApS
CVR number
33958943
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. september 2011
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at producere, importere, distribuere og eksportere, geneksportere medicinsk apparater, udstyr, for brugsartikler samt at yde rådgivning omkring hospitalsplanlægning.
Address
Peder Skrams Vej 27
Phone
+4550312912
Email
nader@zenoumed.com
Website
www.zenoumed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -126 | 4.416 | 3.349 | 2.569 | -1.689 | 5.199 | -137 | -2.065 | 3.384 | -101 | 413 | -164 | -101 |
| Staff expenses | -90 | -540 | -1.181 | -1.260 | -1.311 | -1.480 | -1.380 | -1.175 | -750 | -892 | -475 | -711 | -558 |
| EBITDA | -216 | 3.876 | 2.168 | 1.308 | -3.000 | 3.719 | -1.517 | -3.240 | 2.634 | -993 | -62 | -875 | -659 |
| Depreciation & amort. | -0 | -0 | -0 | -6 | -22 | -26 | -27 | -26 | -31 | -15 | -0 | -0 | -0 |
| EBIT | -216 | 3.876 | 2.168 | 1.302 | -3.022 | 3.693 | -1.544 | -3.266 | 2.603 | -1.008 | -62 | -875 | -659 |
| Net financials | -371 | -333 | 260 | 1.354 | -57 | -551 | 51 | 49 | 8 | 66 | 46 | -29 | 37 |
| Profit before tax | -286 | 3.543 | 2.428 | 2.657 | -3.079 | 3.142 | -1.493 | -3.217 | 2.610 | -942 | -16 | -904 | -622 |
| Tax | 150 | 886 | 605 | 622 | -687 | 692 | -328 | -707 | 567 | 8 | -0 | -151 | -96 |
| Net profit | -436 | 2.657 | 1.823 | 2.035 | -2.392 | 2.451 | -1.165 | -2.510 | 2.044 | -950 | -16 | -753 | -526 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.536 | 7.519 | 12.126 | 8.432 | 4.830 | 6.403 | 5.257 | 2.784 | 4.939 | 3.457 | 4.585 | 2.588 | 2.012 |
| Equity | -373 | 2.284 | 4.107 | 6.142 | 3.750 | 6.200 | 5.036 | 2.526 | 4.569 | 3.119 | 2.604 | 1.851 | 1.324 |
| Long-term debt | 0 | 0 | 0 | 3 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.909 | 5.235 | 8.019 | 2.286 | 1.081 | 198 | 221 | 258 | 369 | 337 | 1.981 | 737 | 688 |
| Total debt | 5.909 | 5.235 | 8.019 | 2.286 | 1.081 | 198 | 221 | 258 | 369 | 337 | 1.981 | 737 | 688 |
EBITDA margin
-65927000.0%
This company
15.8%
Market median
-417259594% vs market
20122024
Equity ratio
65.8%
This company
38.2%
Market median
+72% vs market
20122024
Return on equity
-39.7%
This company
18.4%
Market median
-316% vs market
20122024
Net profit margin
-52628000.0%
This company
8.1%
Market median
-649728495% vs market
20122024
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20122024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Founder | Founder | 2011 | — | — |
NR Management | Management | 2011 | — | — |
AN Founder | Founder | 2011 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NADER HOLDING ApS | Company | 100.0% | 100.0% | 2020 |
| Individual | 90.0% | 90.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NADER HOLDING ApS
ZENOUMED ApS Board members of ZENOUMED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| KIAMEX S.L. | Founder | 0 companies |
| Nader Rasuli-Oskuii | Management | 0 companies |
| Amir Nasehzadeh | Founder | 0 companies |